WINNIPEG, MANITOBA -- (Marketwire) -- 11/27/09 -- Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms (the "Company"), today announces that it has increased the current private placement offering (the "Offering"), first reported on November 16, 2009, from a maximum of 3,846,154 units ("Units") to 4,335,500 Units, for total gross proceeds of up to $563...
More perspectives...
From pr-inside.com
()
Recently, we posted about misadventures of the leadership of biotechnology giant Genzyme. Although the company has long priced its drug Cerezyme for the rare Gaucher's disease at a stratospheric level, it did not sufficiently reinvest money in its manufacturing facility for the drug. Deferred maintenance at a production facility running at maximum capacity has apparently lead to two different kinds of contamination problems, forcing a shut...
More perspectives...
From hcrenewal.blogspot.com
()
The agricultural biotechnology industry maintains that the Insect Resistance Management (IRM) Plan has been one of the most successful industry stewardship programs implemented since pest-tolerant biotech crops were introduced more than a decade ago.
More perspectives...
From medicalnewstoday.com
()
(MENAFN - Jordan Times) Representatives of science and technology institutions, researchers and religious leaders convened on Monday to agree on an code of ethics for the biotechnology industry in Jor...
More perspectives...
From jordannews.net
()
By Wafa Samara AMMAN - Representatives of science and technology institutions, researchers and religious leaders convened on Monday to agree on an code of ethics for the biotechnology industry in Jor...
More perspectives...
From jordannews.net
()
